Abstract
We report two cases maintained on continuous ambulatory peritoneal dialysis (CAPD) who developed destructive spondyloarthropathy (DSA). One patient was a 59-year-old male who had been on CAPD for 10 years, the other a 43-year-old female on CAPD for 5 years who had been maintained on hemodialysis for the previous 10 years. Their DSA were progressive despite adequate CAPD treatment. Thus, CAPD treatment is not sufficient for the removal of β2-microglobulin. Dialysis associated amyloidosis, such as DSA, should be avoided in CAPD patients as well as long-term hemodialysis patients.
